Sa1935 Population Pharmacokinetic Modeling Analysis of Golimumab in Adult Patients With Moderately to Severely Active Ulcerative ColitisOmoniyi J. Adedokun, William J. Sandborn, Rick Strauss et al.|Gastroenterology|2016Cited by 7
Mo1790 Safety, Efficacy, and Pharmacokinetics of Golimumab in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT-SC Long term ExtensionWalter Reinisch, Dino Tarabar, William J. Sandborn et al.|Gastroenterology|2016Cited by 1